| Product Code: ETC9979083 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Viral Vector Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Viral Vector Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Viral Vector Market - Industry Life Cycle |
3.4 United States (US) Viral Vector Market - Porter's Five Forces |
3.5 United States (US) Viral Vector Market Revenues & Volume Share, By Vector Type, 2021 & 2031F |
3.6 United States (US) Viral Vector Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) Viral Vector Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Viral Vector Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in gene therapy research and development |
4.2.2 Growing prevalence of genetic disorders and chronic diseases |
4.2.3 Rising demand for viral vectors in vaccine development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for viral vector-based therapies |
4.3.2 High manufacturing costs associated with viral vector production |
5 United States (US) Viral Vector Market Trends |
6 United States (US) Viral Vector Market, By Types |
6.1 United States (US) Viral Vector Market, By Vector Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Viral Vector Market Revenues & Volume, By Vector Type, 2021- 2031F |
6.1.3 United States (US) Viral Vector Market Revenues & Volume, By Adeno-associated Virus (AAV), 2021- 2031F |
6.1.4 United States (US) Viral Vector Market Revenues & Volume, By Adenovirus, 2021- 2031F |
6.1.5 United States (US) Viral Vector Market Revenues & Volume, By Lentivirus, 2021- 2031F |
6.1.6 United States (US) Viral Vector Market Revenues & Volume, By Retrovirus, 2021- 2031F |
6.1.7 United States (US) Viral Vector Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Viral Vector Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Viral Vector Market Revenues & Volume, By Cell & Gene Therapy, 2021- 2031F |
6.2.3 United States (US) Viral Vector Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.4 United States (US) Viral Vector Market Revenues & Volume, By Biopharmaceutical & Pharmaceutical Discovery, 2021- 2031F |
6.3 United States (US) Viral Vector Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Viral Vector Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.3 United States (US) Viral Vector Market Revenues & Volume, By Academics & Research Institutes, 2021- 2031F |
6.3.4 United States (US) Viral Vector Market Revenues & Volume, By CROs & CMOs, 2021- 2031F |
7 United States (US) Viral Vector Market Import-Export Trade Statistics |
7.1 United States (US) Viral Vector Market Export to Major Countries |
7.2 United States (US) Viral Vector Market Imports from Major Countries |
8 United States (US) Viral Vector Market Key Performance Indicators |
8.1 Number of clinical trials utilizing viral vectors in the US |
8.2 Adoption rate of viral vector-based therapies in different disease areas |
8.3 Research and development expenditure on viral vector technologies in the US |
9 United States (US) Viral Vector Market - Opportunity Assessment |
9.1 United States (US) Viral Vector Market Opportunity Assessment, By Vector Type, 2021 & 2031F |
9.2 United States (US) Viral Vector Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) Viral Vector Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Viral Vector Market - Competitive Landscape |
10.1 United States (US) Viral Vector Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Viral Vector Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here